⌘K
t
Anita Hyman, a Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC), made an initial notification regarding the purchase of 44 Ordinary Shares in BioPharma Credit PLC. This transaction occurred on 15 February 2022 on the London Stock Exchange at a price of £0.736118 per share, acquired as part of a dividend reinvestment.
| Date | 18 Feb 2022 |
| Time | 16:37:04 |
| Category | Director/PDMR dealings |
| ID | 1859C |
BIOPHARMA CREDIT PLC
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
|
1. |
Details of person discharging managerial responsibilities/person closely associated with them |
||||||
|
a) |
Name |
Anita Hyman |
|||||
|
2. |
Reason for the notification |
||||||
|
a) |
Position / status |
Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC) |
|||||
|
b) |
Initial notification / amendment |
Initial notification |
|||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name |
BioPharma Credit PLC |
|||||
|
b) |
LEI |
213800AV55PYXAS7SY24 |
|||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument
Identification Code |
Ordinary Shares of $0.01 each
GB00BDGKMY29 |
|||||
|
b) |
Nature of the transaction |
Purchase of Shares (acquired as part of dividend reinvestment) |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information - Aggregated volume
- Price |
N/A
|
|||||
|
e) |
Date of the transaction |
15.02.22 |
|||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||||